Medacta Group SA Stock

Equities

MOVE

CH0468525222

Medical Equipment, Supplies & Distribution

Market Closed - Swiss Exchange 11:30:11 2024-04-19 am EDT 5-day change 1st Jan Change
110.6 CHF +0.18% Intraday chart for Medacta Group SA -4.98% -11.94%

Financials

Sales 2024 * 596M 635M 578M Sales 2025 * 665M 709M 645M Capitalization 2.27B 2.42B 2.2B
Net income 2024 * 72M 76.7M 69.79M Net income 2025 * 84M 89.48M 81.42M EV / Sales 2024 * 4.07 x
Net Debt 2024 * 151M 161M 146M Net Debt 2025 * 143M 152M 138M EV / Sales 2025 * 3.63 x
P/E ratio 2024 *
30.8 x
P/E ratio 2025 *
26.9 x
Employees 1,696
Yield 2024 *
0.7%
Yield 2025 *
0.78%
Free-Float 30.01%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.18%
1 week-4.98%
Current month-9.64%
1 month-9.79%
3 months-10.08%
6 months+4.34%
Current year-11.94%
More quotes
1 week
107.80
Extreme 107.8
117.20
1 month
107.80
Extreme 107.8
126.00
Current year
107.80
Extreme 107.8
135.00
1 year
98.10
Extreme 98.1
135.00
3 years
76.70
Extreme 76.7
173.00
5 years
39.80
Extreme 39.8
173.00
10 years
39.80
Extreme 39.8
173.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 47 18-10-31
Director of Finance/CFO 56 07-12-31
Sales & Marketing - -
Members of the board TitleAgeSince
Director/Board Member 64 20-12-17
Director/Board Member 67 18-12-31
Director/Board Member 59 18-12-31
More insiders
Date Price Change Volume
24-04-19 110.6 +0.18% 12,511
24-04-18 110.4 -2.30% 14,273
24-04-17 113 -1.74% 10,486
24-04-16 115 -1.03% 9,953
24-04-15 116.2 -0.17% 9,009

Delayed Quote Swiss Exchange, April 19, 2024 at 11:30 am EDT

More quotes
Medacta International SA is a Swiss-based company specialized in medical devices. The Company develops, manufactures and distributes orthopaedic and neurosurgical medical devices. The Company designs a number of products, such as hip products, including hip replacement, hip anatomy, hip diseases, and other products for the preparation of hip surgery; knee product, which encompasses knee anatomy, knee diseases, knee replacement, the stability of the knee and for the preparation of knee surgery; shoulder product, which includes shoulder anatomy, shoulder disease, shoulder replacement, and for the preparation of shoulder operation, and spine product, which includes products for spinal treatments, spinal anatomy and for surgery, among others. Additionally, the Company also offers training and support to healthcare professionals.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
114.1 EUR
Average target price
147 EUR
Spread / Average Target
+28.84%
Consensus

Quarterly revenue - Rate of surprise